MENU
BIIB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Biogen (BIIB) Earnings Date & Reports
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
BIIB is expected to report earnings to fall 11.20% to $3.17 per share on July 29
Q2'26
Est.
$3.17
Q1'26
Beat
by $0.62
Q4'25
Beat
by $0.38
Q3'25
Beat
by $0.93
Q2'25
Beat
by $1.48
The last earnings report on April 29 showed earnings per share of $3.57, beating the estimate of $2.95. With 1.02M shares outstanding, the current market capitalization sits at 29.12B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders
Industry PharmaceuticalsMajor
Profile
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7500
Web
https://www.biogen.com